Left ventricular outflow tract obstruction in patients with Ebstein anomaly.

Ebstein anomaly left ventricular outflow tract obstruction

Journal

JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 07 09 2023
revised: 04 10 2023
accepted: 10 10 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

In this study, we investigated the clinical characteristics of patients with Ebstein anomaly and left ventricular outflow tract (LVOT) obstruction as well as possible mechanisms of obstruction as assessed by 2-dimensional echocardiography. We queried our institutional echocardiography and surgical databases for patients with the diagnosis of Ebstein anomaly seen from 1985 through 2022. Fourteen patients had the additional diagnosis of LVOT obstruction identified from transthoracic echocardiography. The mean age of the 14 patients at the time that LVOT obstruction was identified was 51.9 ± 9.9 years, and 11 (78%) were female. LVOT obstruction (mean gradient 61.0 ± 25.7 mm Hg) was documented at the time of initial diagnosis of Ebstein anomaly for 8, and in the remaining, was recognized on follow-up imaging. Dynamic LVOT obstruction with systolic anterior motion (SAM) was the most common mechanism and was mostly accompanied by leftward septal movement and septal hypertrophy. Seven of the 9 patients with SAM had the diagnosis of hypertrophic cardiomyopathy. Leftward bowing of the septum appeared to be the sole cause of LVOT obstruction in 3 and a contributing factor to SAM in 4. Among the 13 patients who underwent an operation for Ebstein anomaly, 7 had concomitant septal myectomy and 3 had a subsequent procedure. There are multiple mechanisms of LVOT obstruction in patients with Ebstein anomaly, including SAM and leftward bowing of the interventricular septum, which may exist alone or in combination. Septal myectomy at the time of tricuspid valvuloplasty is safe and effectively reduces gradients in the outflow tract and may prevent the need for subsequent reintervention.

Identifiants

pubmed: 38204684
doi: 10.1016/j.xjon.2023.10.024
pii: S2666-2736(23)00342-X
pmc: PMC10775129
doi:

Types de publication

Journal Article

Langues

eng

Pagination

641-647

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.

Auteurs

Defne Gunes Ergi (DG)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Hartzell V Schaff (HV)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Heidi M Connolly (HM)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.

William R Miranda (WR)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.

David S Majdalany (DS)

Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Ariz.

Joseph M Dearani (JM)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Classifications MeSH